Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader
April 1, 2026
SANTA CLARA, Calif. -- Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform. Building on a decade of Cytation innovation and shaped by continuous customer feedback, the [...]
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
April 1, 2026
BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and diagnostics industry executive with decades of relevant leadership, strategic and operational experience. Thierry Bernard Frank H. Laukien, the Chairman, President and CEO [...]
Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents
April 1, 2026
REDWOOD CITY, Calif. -- Synthego, a pioneering leader in genome engineering solutions, today announced that the Supreme Court of the United States has denied a petition for a writ of certiorari from Agilent Technologies, Inc., effectively concluding a multi-year legal challenge and solidifying the invalidation of two Agilent CRISPR-related patents that claimed a widely used [...]
March 31, 2026
San Jose, CA, -- Rtec Instruments, a global leader in surface characterization and tribology solutions, announces the acquisition of Micro Materials Ltd., a UK-based pioneer in micro- and nanoindentation technologies. This strategic partnership represents a major step forward for both companies, combining complementary expertise to accelerate growth in the field of mechanical surface testing—particularly in [...]
PRISM ALS: New stem cell models could transform research into treatments for MND/ALS
March 31, 2026
PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving access to specially grown, patient-derived stem cell models that better reflect the biological diversity of the disease. The collaboration brings together ALS Therapy Development Institute (ALS TDI), LifeArc, and Axol Bioscience to develop high-quality induced pluripotent [...]
Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM
March 31, 2026
Equipped with the READY System to make structural biology research accessible to more labs News: Thermo Fisher Scientific, the world leader in serving science, today introduces a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural biology with greater clarity — now accessible in more lab environments than ever before. The Thermo Scientific™ Glacios™ [...]
March 31, 2026
Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform Cambridge, UK: Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP). The fundraise was led by Parkwalk, and [...]
New ZEISS Crossbeam 750 FIB-SEM for high-accuracy sample preparation workflows
March 31, 2026
Advances in simultaneous SEM imaging while FIB milling provide unmatched feedback for precision endpointing New ZEISS Gemini 4 electron optics offer superior resolution and signal-to-noise ratio Live SEM imaging extended to monitor rapid FIB milling down to ultrafine lamella polishing Largest undistorted field-of-view supports the best outcomes in 3D tomography and APT workflows Jena, Germany [...]
March 31, 2026
Rebrand follows appointment of new leadership as company drives commercialization of INDUCE-seq platform to address regulatory gaps in off-target reporting for gene editing programs Cambridge, UK – Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of [...]
March 31, 2026
Pioneering genomics researcher and Methods Development Lab director joins n6 to accelerate adoption of AutoNorm across the research and clinical genomics community PLEASANTON, Calif. -- n6 Tec, Inc. (n6), the developer of icon96™, the first and only intelligent thermocycler platform with real-time, per-well adaptive amplification (iconPCR™ with AutoNorm), today announced the appointment of Dr. Aziz Al'Khafaji [...]

